Using omics and other data, researchers performed network analyses that pointed to interactions between human herpesviruses and other Alzheimer's disease risk factors.
A study finds that male science students have higher opinions of their abilities than female students earning the same grade, the New York Times reports.
In PLOS this week: ramifications of sexual recombination in bacteria, Mycobacterium leprae genome sequences, and more.
The Biomedical Advanced Research and Development Authority aims to produce at least two US Food and Drug Administration-cleared tests.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
A lawyer and a scientist say the best result in the CRISPR patent fight would be narrow patents that prevent anyone from controlling downstream innovation.
The researchers also found fixed variants in the tortoise genome linked to the immune system, which may help manage the health of the threatened species.
New data from Peregrine Pharmaceuticals, along with other recent research, suggests that surface proteins can be used to isolate cancer-specific exosomes to detect the presence of a tumor.
Researchers showed it could differentiate pancreatic cancer cases from controls with high sensitivity, and believe it could work similarly for other cancers or in infectious disease.
Robert Cook-Deegan and Subhashini Chandrasekharan discuss genetic testing patents in the New England Journal of Medicine.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.